References
- Ahmed SM, Hall AJ, Robinson AE, Verhoef L, Premkumar P, Parashar UD, Koopmans M, Lopman BA. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(8):725–730. doi:https://doi.org/10.1016/S1473-3099(14)70767-4.
- Mattison CP, Cardemil CV, Hall AJ. Progress on norovirus vaccine research: Public health considerations and future directions. Expert review of vaccines. 2018 Sep 2;17(9):773–784. doi: https://doi.org/10.1080/14760584.2018.1510327
- Hall AJ, Diab S, McGraw S, Barr B, Traslavina R, Higgins R, Talbot T, Blanchard P, Rimoldi G, Fahsbender E, et al. Norovirus disease in the United States. Emerging Infect Dis. 2013;19(8):1198. doi:https://doi.org/10.3201/eid1909.130682.
- Pringle K, Lopman B, Vega E, Vinje J, Parashar UD, Hall AJ. Noroviruses: epidemiology, immunity and prospects for prevention. Future Microbiol. 2015;10(1):53–67. doi:https://doi.org/10.2217/fmb.14.102.
- Debbink K, Lindesmith LC, Baric RS. The state of norovirus vaccines. Clin Infect Dis. 2014;58(12):1746–1752. doi:https://doi.org/10.1093/cid/ciu120.
- Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, Neill FH, Graham DY. Norwalk virus shedding after experimental human infection. Emerging Infect Dis. 2008;14(10):1553–1557. doi:https://doi.org/10.3201/eid1410.080117.
- Lopman B, Gastañaduy P, Park GW, Hall AJ, Parashar UD, Vinjé J. Environmental transmission of norovirus gastroenteritis. Curr Opin Virol. 2012;2(1):96–102. doi:https://doi.org/10.1016/j.coviro.2011.11.005.
- Ramani S, Atmar RL, Estes MK. Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol. 2014;30(1):25–33. doi:https://doi.org/10.1097/MOG.0000000000000022.
- Hall AJ, Wikswo ME, Pringle K, Gould LH, Parashar UD. Vital signs: foodborne norovirus outbreaks-United States, 2009-2012. MMWR Morb Mortal Wkly Rep. 2014;63(22):491–495.
- Lopman BA, Hall AJ, Curns AT, Parashar UD. Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996–2007. Clin Infect Dis. 2011;52(4):466–474. doi:https://doi.org/10.1093/cid/ciq163.
- Aliabadi N, Lopman BA, Parashar UD, Hall AJ. Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations. Expert Rev Vaccines. 2015;14(9):1241–1253. doi:https://doi.org/10.1586/14760584.2015.1073110.
- Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY. The potential economic value of a human norovirus vaccine for the United States. Vaccine. 2012;30(49):7097–7104. doi:https://doi.org/10.1016/j.vaccine.2012.09.040.
- Kim L, Jacobsen KM, Henry CJ, Huey MG, Parker RE, Page LS, Hill AA, Wang X, Frye SV, Earp HS, et al. Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial. JCI Insight. 2018;3(13). doi:https://doi.org/10.1172/jci.insight.97941.
- Vinjé J. Advances in laboratory methods for detection and typing of norovirus. J Clin Microbiol. 2015;53(2):373–381. doi:https://doi.org/10.1128/JCM.01535-14.
- Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, Estes MK, Graham DY, Opekun AR, Richardson C, et al. Norovirus vaccine against experimental human Norwalk Virus illness. New England J Med. 2011;365(23):2178–2187. doi:https://doi.org/10.1056/NEJMoa1101245.
- Swanstrom J, Lindesmith LC, Donaldson EF, Yount B, Baric RS. Characterization of blockade antibody responses in GII. 2.1976 Snow Mountain virus-infected subjects. J Virol. 2014;88(2):829–837. doi:https://doi.org/10.1128/JVI.02793-13.
- Vega E, Barclay L, Gregoricus N, Shirley SH, Lee D, Vinjé J. Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013. J Clin Microbiol. 2014;52(1):147–155. doi:https://doi.org/10.1128/JCM.02680-13.
- Cortes-Penfield NW, Ramani S, Estes MK, Atmar RL. Prospects and challenges in the development of a norovirus vaccine. Clin Ther. 2017;39(8):1537–1549. doi:https://doi.org/10.1016/j.clinthera.2017.07.002.
- Burke RM, Shah MP, Wikswo ME, Barclay L, Kisselburgh H, Kambhampati A, Marsh Z, Cannon JL, Parashar UD, Vinjé J, Hall AJ. The norovirus epidemiologic triad: Predictors of severe outcomes in US Norovirus Outbreaks, 2009–2016. The Journal of Infectious Diseases. 2018 Nov 15.
- Lindesmith LC, Donaldson EF, Baric RS. Norovirus GII. 4 strain antigenic variation. J Virol. 2011;85(1):231–242. doi:https://doi.org/10.1128/JVI.01364-10.
- Debbink K, Lindesmith LC, Donaldson EF, Costantini V, Beltramello M, Corti D, Swanstrom J, Lanzavecchia A, Vinjé J, Baric RS. Emergence of new pandemic GII. 4 Sydney norovirus strain correlates with escape from herd immunity. J Infect Dis. 2013;208(11):1877–1887. doi:https://doi.org/10.1093/infdis/jit370.
- Chan MC, Wang N, Wilksch JJ, Page AJ, Cao H, Gujaran S, Keane JA, Lithgow T, Ul-Haq I, Dougan G, et al. Global spread of norovirus GII. 17 Kawasaki 308, 2014–2016. Emerging Infect Dis. 2017;23(8):1350. doi:https://doi.org/10.3201/eid2311.170833.
- Ao Y, Cong X, Jin M, Sun X, Wei X, Wang J, Zhang Q, Song J, Yu J, Cui J, et al. Genetic analysis of reemerging GII. P16-GII. 2 Noroviruses in 2016–2017 in China. J Infect Dis. 2018;218(1):133–143. doi:https://doi.org/10.1093/infdis/jiy182.
- Saito M, Goel-Apaza S, Espetia S, Velasquez D, Cabrera L, Loli S, Crabtree JE, Black RE, Kosek M, Checkley W, et al. Multiple norovirus infections in a birth cohort in a Peruvian periurban community. Clin Infect Dis. 2013;58(4):483–491. doi:https://doi.org/10.1093/cid/cit763.
- Bernstein DI, Atmar RL, Lyon GM, Treanor JJ, Chen WH, Jiang X, Vinjé J, Gregoricus N, Frenck RW, Moe CL, et al. Norovirus vaccine against experimental human GII. 4 virus illness: a challenge study in healthy adults. J Infect Dis. 2014;211(6):870–878. doi:https://doi.org/10.1093/infdis/jiu497.
- Johnson PC, Mathewson JJ, DuPont HL, Greenberg HB. Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis. 1990;161(1):18–21.
- Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR. Clinical immunity in acute gastroenteritis caused by Norwalk agent. New England J Med. 1977;297(2):86–89. doi:https://doi.org/10.1056/NEJM197707142970204.
- Wyatt RG, Dolin R, Blacklow NR, DuPont HL, Buscho RF, Thornhill TS, Kapikian AZ, Chanock RM. Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis. 1974;129(6):709–714.
- Simmons K, Diab S, McGraw S, Barr B, Traslavina R, Higgins R, Talbot T, Blanchard P, Rimoldi G, Fahsbender E, et al. Duration of immunity to norovirus gastroenteritis. Emerging Infect Dis. 2013;19(8):1260. doi:https://doi.org/10.3201/eid1909.130682.
- Ramani S, Estes MK, Atmar RL. Correlates of protection against norovirus infection and disease—where are we now, where do we go? PLoS Pathog. 2016;12(4):e1005334. doi:https://doi.org/10.1371/journal.ppat.1005334.
- Ettayebi K, Crawford SE, Murakami K, Broughman JR, Karandikar U, Tenge VR, Neill FH, Blutt SE, Zeng XL, Qu L, Kou B. Replication of human noroviruses in stem cell–derived human enteroids. Science. 2016 Aug 25:aaf5211. doi: https://doi.org/10.1126/science.aaf5211
- Phillips G, Tam CC, Conti S, Rodrigues LC, Brown D, Iturriza-Gomara M, Gray J, Lopman B. Community incidence of norovirus-associated infectious intestinal disease in England: improved estimates using viral load for norovirus diagnosis. Am J Epidemiol. 2010;171(9):1014–1022. doi:https://doi.org/10.1093/aje/kwq021.
- Lindsay L, Wolter J, De Coster I, Van Damme P, Verstraeten T. A decade of norovirus disease risk among older adults in upper-middle and high income countries: a systematic review. BMC Infect Dis. 2015;15(1):425. doi:https://doi.org/10.1186/s12879-015-1168-5.
- Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999–2007. Clin Infect Dis. 2012;55(2):216–223. doi:https://doi.org/10.1093/cid/cis386.
- Trivedi TK, Desai R, Hall AJ, Patel M, Parashar UD, Lopman BA. Clinical characteristics of norovirus-associated deaths: a systematic literature review. Am J Infect Control. 2013;41(7):654–657. doi:https://doi.org/10.1016/j.ajic.2012.08.002.
- Harris JP, Edmunds WJ, Pebody R, Brown DW, Lopman BA. Deaths from norovirus among the elderly, England and Wales. Emerging Infect Dis. 2008;14(10):1546–1552. doi:https://doi.org/10.3201/eid1410.080188.
- Steele MK, Remais JV, Gambhir M, Glasser JW, Handel A, Parashar UD, Lopman BA. Targeting pediatric versus elderly populations for norovirus vaccines: a model-based analysis of mass vaccination options. Epidemics. 2016;17:42–49. doi:https://doi.org/10.1016/j.epidem.2016.10.006.
- Yang W, Steele M, Lopman B, Leon JS, Hall AJ. The population-level impacts of excluding norovirus-infected food workersfrom the workplace: A mathematical modeling study. American Journal of Epidemiology. 2018 Sep 7. doi:https://doi.org/10.1093/aje/kwy198
- Kirk MD, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, et al. World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis. PLoS Med. 2015;12(12):e1001921. doi:https://doi.org/10.1371/journal.pmed.1001809.
- Pires SM, Fischer-Walker CL, Lanata CF, Devleesschauwer B, Hall AJ, Kirk MD, Duarte ASR, Black RE, Angulo FJ, Selvey LA. Aetiology-specific estimates of the global and regional incidence and mortality of diarrhoeal diseases commonly transmitted through food. PLoS ONE. 2015;10(12):e0142927. doi:https://doi.org/10.1371/journal.pone.0142927.
- Lopman B, Kang G. Editorial commentary: in praise of birth cohorts: norovirus infection, disease, and immunity. Oxford University Press; 2013. doi: https://doi.org/10.1093/cid/cit785
- Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382(9888):209–222. doi:https://doi.org/10.1016/S0140-6736(13)60844-2.
- Lopman B, Simmons K, Gambhir M, Vinjé J, Parashar U. Epidemiologic implications of asymptomatic reinfection: a mathematical modeling study of norovirus. Am J Epidemiol. 2013;179(4):507–512. doi:https://doi.org/10.1093/aje/kwt287.